Page 94 - GPD-4-2
P. 94

Gene & Protein in Disease                                              Regulatory elements of ATP7B in WD



            14.  Gonzales E, Davit-Spraul A, Baussan C, Buffet C, Maurice M,   promoter alleviates promoter competition and reactivates
               Jacquemin E. Liver diseases related to MDR3 (ABCB4) gene   fetal globin gene expression. Blood. 2022;139(14):2107-2118.
               deficiency. Front Biosci (Landmark Ed). 2009;14(11):4242-4256.
                                                                  doi: 10.1182/blood.2021014205
               doi: 10.2741/3526                               26.  Kleinjan DA, Seawright A, Schedl A, Quinlan RA, Danes S,
            15.  Marchi G, Busti F, Lira Zidanes A, Castagna A, Girelli D.   van Heyningen V. Aniridia-associated translocations, DNase
               Aceruloplasminemia: A severe neurodegenerative disorder   hypersensitivity, sequence comparison and transgenic
               deserving an early diagnosis. Front Neurosci. 2019;13:325.  analysis redefine the functional domain of PAX6. Hum Mol
                                                                  Genet. 2001;10(19):2049-2059.
               doi: 10.3389/fnins.2019.00325
                                                                  doi: 10.1093/hmg/10.19.2049
            16.  Jaeken J, Matthijs G. Congenital disorders of glycosylation.
               Annu Rev Genomics Hum Genet. 2001;2:129-151.    27.  Pradhan S, Sengupta M, Dutta A,  et al. Indian genetic
                                                                  disease database. Nucleic Acids Res. 2011;39:D933-D938.
               doi: 10.1146/annurev.genom.2.1.129
                                                                  doi: 10.1093/nar/gkq1025
            17.  Ranucci G, Iorio R. Disorders that mimic Wilson disease.
               In: Clinical and Translational Perspectives on Wilson Disease.   28.  Gupta A, Chattopadhyay I, Dey S,  et al. Molecular
               Amsterdam, Netherlands: Elsevier. 2019;41:419-426.  pathogenesis of Wilson disease among Indians: A perspective
                                                                  on mutation spectrum in ATP7B gene, prevalent defects,
               doi: 10.1016/B978-0-12-810532-0.00041-0
                                                                  clinical heterogeneity and implication towards diagnosis.
            18.  Mukherjee S, Dutta S, Majumdar S, et al. Genetic defects   Cell Mol Neurobiol. 2007;27(8):1023-1033.
               in Indian Wilson disease patients and genotype-phenotype      doi: 10.1007/s10571-007-9192-7
               correlation. Parkinsonism Relat Disord. 2014;20(1):75-81.
                                                               29.  Gupta A, Aikath D, Neogi R, et al. Molecular pathogenesis
               doi: 10.1016/j.parkreldis.2013.09.021
                                                                  of Wilson disease: Haplotype analysis, detection of prevalent
            19.  Todorov T, Balakrishnan P, Savov A, Socha P, Schmidt HH.   mutations and genotype-phenotype correlation in Indian
               Intragenic deletions in ATP7B as an unusual molecular   patients. Hum Genet. 2005;118(1):49-57.
               genetics mechanism of Wilson’s disease pathogenesis. PLoS
               One. 2016;11(12):e0168372.                         doi: 10.1007/s00439-005-0007-y
                                                               30.  Aggarwal A, Bhatt M. Update on Wilson disease. Int Rev
               doi: 10.1371/journal.pone.0168372
                                                                  Neurobiol. 2013;110:313-348.
            20.  Roy S, Ghosh S, Ray J, Ray K, Sengupta M. Missing heritability      doi: 10.1016/B978-0-12-410502-7.00014-4
               of Wilson disease: A  search for the uncharacterized
               mutations. Mamm Genome. 2023;34(1):1-11.        31.  Cullen LM, Prat L, Cox DW. Genetic variation in the promoter
                                                                  and 5’ UTR of the copper transporter, ATP7B, in patients with
               doi: 10.1007/s00335-022-09971-y
                                                                  Wilson disease. Clin Genet. 2003;64(5):429-432.
            21.  Teschke R, Eickhoff A. Wilson disease: Copper-mediated
               cuproptosis, iron-related ferroptosis, and clinical highlights,      doi: 10.1034/j.1399-0004.2003.00160.x
               with comprehensive and critical analysis update. Int J Mol   32.  Loudianos G, Dessi V, Lovicu M,  et al. Molecular
               Sci. 2024;25(9):4753.                              characterization of Wilson disease in the Sardinian population-
                                                                  -evidence of a founder effect. Hum Mutat. 1999;14(4):294-303.
               doi: 10.3390/ijms25094753
                                                                  doi:    10.1002/(SICI)1098-1004(199910)14:4<294:AID-
            22.  Liu Y, Li C, Shen S, et al. Discovery of regulatory noncoding   HUMU4>3.0.CO;2-9
               variants in individual cancer genomes by using cis-X. Nat
               Genet. 2020;52(8):811-818.                      33.  Yang CS, Liang XL, Li JY, Yan ZW, Huang F. Effect of the
                                                                  mutation of promoter region in Wilson disease ATP7B gene
               doi: 10.1038/s41588-020-0659-5
                                                                  on the expression of reporter gene.  Zhonghua Yi Xue Yi
            23.  Subramanian A, Su S, Moding EJ, Binkley MS. Investigating   Chuan Xue Za Zhi. 2005;22(5):566-568.
               the tissue specificity and prognostic impact of cis-regulatory   34.  Wan L, Tsai CH, Hsu CM,  et al. Mutation analysis and
               cancer risk variants. Hum Genet. 2023;142(9):1395-1405.
                                                                  characterization of alternative splice variants of the Wilson
               doi: 10.1007/s00439-023-02586-6                    disease gene ATP7B. Hepatology. 2010;52(5):1662-1670.
            24.  Ichiyama-Kobayashi S, Hata K, Wakamori K,  et al.      doi: 10.1002/hep.23865
               Chromatin  profiling identifies chondrocyte-specific  Sox9   35.  Chen HI, Jagadeesh KA, Birgmeier J, et al. An MTF1 binding
               enhancers important for skeletal development. JCI Insight.   site disrupted by a homozygous variant in the promoter
               2024;9(11):e175486.
                                                                  of ATP7B likely causes Wilson Disease. Eur J Hum Genet.
               doi: 10.1172/jci.insight.175486                    2018;26(12):1810-1818.
            25.  Topfer SK, Feng R, Huang P, et al. Disrupting the adult globin      doi: 10.1038/s41431-018-0221-4


            Volume 4 Issue 2 (2025)                         8                               doi: 10.36922/gpd.7503
   89   90   91   92   93   94   95   96   97   98   99